These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4150819)

  • 1. Haemodynamic effects of beta blockade in hypertrophic cardiomyopathy using Sectral (acebutolol; M and B 17803A).
    Lewis BS; Mitha AS; Bakst A; Purdon K; Gotsman MS
    Cardiovasc Res; 1974 Mar; 8(2):249-62. PubMed ID: 4150819
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A).
    Lewis BS; Bakst A; Mitha AS; Purdon K; Gotsman MS
    Br Heart J; 1973 Jul; 35(7):743-51. PubMed ID: 4146280
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
    Weiss L; Lundgren Y; Folkow B
    Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of left ventricular outflow obstruction in idiopathic hypertrophic subaortic stenosis. Report of a case.
    Williams RG; Ellison RC; Nadas AS
    N Engl J Med; 1973 Apr; 288(17):868-71. PubMed ID: 4266353
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardioselective beta blockade in hypertrophic cardiomyopathy.
    Webb-Peplos MM; Croxson RS; Khanna P; Raphael MJ; Steiner RE; Oakley CM; Goodwin JF
    Acta Cardiol; 1972; ():Suppl 15:263-7. PubMed ID: 4147610
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of autonomic blockade on the reduction in myocardial performance produced by clonidine.
    Laubie M; Schmitt H
    Eur J Pharmacol; 1974 Jan; 25(1):56-65. PubMed ID: 4154847
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of alpha- and beta-receptor blockade on systolic time intervals.
    Frei F; Imhof P; Dubach UC
    Eur J Clin Pharmacol; 1974; 7(1):1-10. PubMed ID: 4152857
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic effects of practolol at rest and during exercise.
    Leon DF; Thompson ME; Shaver JA; McDonald RH
    Circulation; 1972 Jan; 45(1):46-54. PubMed ID: 4399771
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man.
    Lewis BS; Bakst A; Kitchiner D; Gotsman MS
    S Afr Med J; 1973 Jul; 47(27):1181-4. PubMed ID: 4146564
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.
    Cuthbert MF; Owusu-Ankomah K
    Br J Pharmacol; 1971 Nov; 43(3):639-48. PubMed ID: 4400530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of M & B 17803A in man.
    Leary WP; Coleman AJ
    S Afr Med J; 1972 Aug; 46(34):1202-3. PubMed ID: 4403479
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
    Reale A; Motolese M; Imhof P
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemodynamic changes in patients with coronary heart disease after beta-adrenergic blockade with propranolol.
    Bürgin D
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):365-70. PubMed ID: 4395489
    [No Abstract]   [Full Text] [Related]  

  • 15. Reappraisal of the effect of acute betablockade on left ventricular filling dynamics in hypertrophic obstructive cardiomyopathy.
    Speiser KW; Krayenbuehl HP
    Eur Heart J; 1981 Feb; 2(1):21-9. PubMed ID: 6115751
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrasound measurements of ventricular wall motion following administration of vasoactive drugs.
    Kraunz RF; Ryan TJ
    Am J Cardiol; 1971 May; 27(5):464-73. PubMed ID: 5102616
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific beta adrenergic blockade by practolol.
    Thompson ME; McDonald RH; Leon DF; Shaver JA
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):750-60. PubMed ID: 4154153
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
    Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodynamic and electrocardiographic effects of practolol during upright exercise in coronary heart disease.
    Rousseau MF; Brasseur LA; Detry JM
    Cardiovasc Res; 1973 May; 7(3):306-12. PubMed ID: 4146653
    [No Abstract]   [Full Text] [Related]  

  • 20. Sectral in the management of angina pectoris.
    Lewis BS; Bakst A; Kitchiner DJ; Gotsman MS
    S Afr Med J; 1973 Aug; 47(32):1455-9. PubMed ID: 4146876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.